ChatGPT for Nuclear Medicine Technologists: 35 Prompts to Write Scan Reports, Patient Education, and Protocol Documentation Faster
Save 73–77% of your documentation time with 35 ChatGPT prompts built for nuclear medicine technologists and CNMTs — bone scan report addendums, patient radiation safety education, QC failure narratives, protocol documentation, and CNMT exam prep.
⚠️ Important: Never enter real patient names, MRNs, dose calibrator serial numbers tied to patients, or any PHI into ChatGPT. Use placeholders like [TECH_NAME], [PHYSICIAN_NAME], [DOSE_MCI], [QC_DATE], [ACCESSION_PLACEHOLDER]. All AI-generated documentation must be reviewed and approved by your supervising nuclear medicine physician and radiation safety officer before filing. AI does not replace physician sign-off or NRC compliance. Follow HIPAA, SNMMI, NRC 10 CFR 35, and your facility's AI policy.
Nuclear medicine technologists perform 10–14 scans per day across stress tests, bone scans, thyroid uptakes, and PET/CT — each requiring documentation of radiopharmaceutical administration, dosimetry, uptake patterns, and clinical findings. Every protocol deviation needs a record. Every QC failure on the gamma camera requires a corrective action narrative before releasing patient studies. Every patient leaving after RAI-131 ablation needs radiation safety instructions they can actually follow at home.
The documentation burden in a busy nuclear medicine department is enormous — and almost nothing in the AI tools space addresses it. ChatGPT can't perform a Tc-99m MDP bone scan or interpret a SPECT/CT. But it eliminates every blank page in your documentation workflow. A bone scan report addendum that used to take 18–25 minutes takes 4–6. A patient RAI education handout drops from 15–20 minutes to under 5. A gamma camera QC failure narrative with full corrective action plan goes from 20–28 minutes to under 6. For a CNMT running 12 scans a day while managing radiopharmaceutical inventory, QC logs, and patient education simultaneously, that's not a minor gain — that's the difference between leaving on time and staying two hours late every Friday.
For related AI documentation strategies across allied health imaging sciences, see ChatGPT for EKG/cardiac monitor technicians, ChatGPT for phlebotomists, and ChatGPT for pharmacy technicians.
How Jamie Okafor, CNMT Cut 3 Daily Documents from 50–60 Minutes to 11–14
Jamie Okafor, CNMT works the day shift in the nuclear medicine department at a large academic medical center in Houston — a tertiary referral center performing 10–14 nuclear medicine studies daily across stress tests, bone scans, thyroid uptakes, and PET/CT. By 10 AM on a busy Thursday, Jamie has already identified three documents that need to be written before noon: a bone scan report addendum for a 3-phase Tc-99m MDP study on a patient referred for back pain rule-out metastatic disease — pathologic uptake at the L4 vertebral body requires a formal addendum documenting the finding and differential; a radiation precaution education handout for a thyroid cancer patient who just completed RAI-131 ablation and needs written NRC-required discharge instructions before leaving the department; and a QC failure log for the department's gamma camera — CFOV integral uniformity came in at 5.3% this morning, exceeding the 5.0% threshold, triggering a service call and an out-of-service documentation record.
Before AI prompts, those three documents ate 50–60 minutes of Jamie's shift. The bone scan addendum required documenting the Tc-99m MDP dose, acquisition parameters for all 3 phases, the L4 focal uptake finding, the differential between compression fracture with hyperemia and metastatic lesion, SNMMI guideline reference for MRI correlation, and physician notification language. The RAI-131 patient education handout needed NRC-compliant radiation precaution language covering distance, isolation days, sleeping separately, avoiding children and pregnant contacts, the toilet flushing protocol, return to work guidance, and the airport security detector warning with carry documentation instructions. The gamma camera QC failure narrative required documenting the CFOV measurement, the threshold exceedance, the out-of-service determination, the service call initiation, affected patients and rerouting plan, and supervisor sign-off language consistent with SNMMI equipment QC standards.
Three documents. Three different clinical formats. Three blank pages. Before AI prompts: 50–60 minutes. After: 11–14 minutes — a 76% reduction.
The prompt Jamie uses for the bone scan addendum + RAI education + gamma camera QC failure workflow:
You are a nuclear medicine department documentation specialist. Generate three separate clinical documents using only de-identified placeholder information. Do not include any real patient identifiers, MRNs, dose calibrator readings, or PHI.
Variables:
Technologist: [TECH_NAME], CNMT
Supervising Physician: Dr. [PHYSICIAN_NAME]
Facility: [FACILITY_NAME], academic medical center nuclear medicine department
Radiopharmaceutical: Tc-99m MDP (technetium-99m methylene diphosphonate)
Dose administered: [DOSE_MCI] mCi (administered activity per departmental protocol)
Gamma Camera: [CAMERA_MODEL_PLACEHOLDER]
QC Date: [QC_DATE]
Accreditation: SNMMI practice guidelines; NRC radiation safety regulations
Document 1 — Bone Scan Report Addendum (3-Phase, Tc-99m MDP):
Patient context: [PATIENT_CONTEXT — age/sex/clinical indication, no name or MRN]. Indication: known [PRIMARY_MALIGNANCY_PLACEHOLDER] — rule out metastatic disease vs. benign etiology. Tc-99m MDP dose: [DOSE_MCI] mCi IV administered at [ADMINISTRATION_TIME]. 3-phase acquisition: flow phase — dynamic images obtained at 2–3 seconds per frame for 60 seconds over the region of interest; blood pool phase — static images at 5 minutes post-injection; delayed static images (whole body and SPECT/CT of lumbar spine) at 3 hours post-injection.
Findings: L4 vertebral body — focal increased radiotracer uptake on all 3 phases (flow, blood pool, and delayed). Distribution: photopenic center with peripheral rim uptake pattern vs. diffuse uptake pattern — [PATTERN_PLACEHOLDER]. Additional findings: [ADDITIONAL_SITES_PLACEHOLDER] (e.g., bilateral sacroiliac joint degenerative changes, mild uptake consistent with osteoarthritis knees).
Addendum purpose: Document L4 uptake finding and differential — compression fracture with associated hyperemia vs. metastatic lesion; recommend correlation with [RECOMMENDED_IMAGING_PLACEHOLDER] (MRI lumbar spine with and without contrast) per SNMMI bone scan reporting guidelines. Attending physician Dr. [PHYSICIAN_NAME] notified of findings at [NOTIFICATION_TIME]. Write approximately 150–175 words in formal nuclear medicine report addendum format.
Document 2 — RAI-131 Post-Ablation Radiation Precautions Patient Education Handout:
Patient context: adult patient s/p RAI-131 (radioiodine-131) ablation for [THYROID_CONDITION_PLACEHOLDER] (e.g., differentiated thyroid cancer post-thyroidectomy, hyperthyroidism). Administered activity: [RAI_DOSE_MCI] mCi I-131. I-131 physical half-life: 8.02 days; effective half-life: approximately [EFFECTIVE_HALFLIFE_DAYS] days (varies with thyroid remnant uptake). NRC threshold for release: administered activity < 33 mCi OR measured exposure rate ≤ 7 mrem/hr at 1 meter — patient meets release criteria.
NRC-required radiation precautions for home isolation period (typically [ISOLATION_DAYS] days):
- Distance: maintain ≥6 feet from others when possible
- Sleep separately from spouse/partner for [SLEEP_SEPARATE_DAYS] nights
- Avoid close contact (within 3 feet for >1 hour) with children and pregnant women for [CHILD_CONTACT_DAYS] days
- Flush toilet twice after use; wash hands thoroughly
- Use separate eating utensils, towels; launder separately
- Return to work guidance: [RETURN_TO_WORK_PLACEHOLDER] (job-dependent — office vs. public contact vs. pregnant coworker exposure)
- Carry [RELEASE_DOCUMENT_PLACEHOLDER] (NRC-compliant written instructions and release document) for [CARRY_DOCUMENT_DAYS] days for airport/security detector purposes
Write approximately 200–225 words in patient education handout format, plain language, ALARA principle referenced.
Document 3 — Gamma Camera Uniformity QC Failure Log:
Camera: [CAMERA_MODEL_PLACEHOLDER]. QC type: daily intrinsic/extrinsic uniformity QC. Date: [QC_DATE]. Technologist: [TECH_NAME], CNMT.
QC result: Center Field of View (CFOV) integral uniformity = [CFOV_RESULT]% (measured). Acceptable threshold per SNMMI/departmental protocol: CFOV ≤5.0% integral uniformity. Differential uniformity: [DFOV_RESULT]% (DFOV threshold: ≤3.0%).
Failure: CFOV >5% — QC FAIL. Camera placed out of service for patient imaging. Corrective action: Physics/biomedical engineering service call initiated at [SERVICE_CALL_TIME]. Dr. [PHYSICIAN_NAME] notified. All patient studies on this camera suspended pending resolution. Service technician [SERVICE_TECH_PLACEHOLDER] contacted via [CONTACT_METHOD]. Estimated resolution time: [ESTIMATED_RESOLUTION]. Patient cases rescheduled or routed to [ALTERNATE_CAMERA_PLACEHOLDER] pending repair. Write approximately 130–155 words in QC failure log format consistent with SNMMI equipment QC standards.Sample Output (Excerpts)
Document 1 — Bone Scan Report Addendum:
NUCLEAR MEDICINE REPORT ADDENDUM — BONE SCAN (3-PHASE Tc-99m MDP)
Technologist: [TECH_NAME], CNMT | Supervising Physician: Dr. [PHYSICIAN_NAME] | Facility: [FACILITY_NAME]
Accession: [ACCESSION_PLACEHOLDER] | QC Date: [QC_DATE]
Radiopharmaceutical: Technetium-99m methylene diphosphonate (Tc-99m MDP), [DOSE_MCI] mCi intravenously administered at [ADMINISTRATION_TIME]. Acquisition protocol: 3-phase study — dynamic flow phase (2-second frames × 30 frames), blood pool phase at 5 minutes post-injection, delayed whole-body planar and SPECT/CT lumbar spine at 3 hours.
Addendum Finding — L4 Vertebral Body: Focal increased radiotracer uptake identified at the L4 vertebral body on all three phases of acquisition. Pattern description: [PATTERN_PLACEHOLDER] — peripheral rim uptake with relative central photopenia on delayed images is more consistent with a compression fracture with associated hyperemia; diffuse homogeneous uptake at the same level raises concern for metastatic lesion, particularly given the clinical history of [PRIMARY_MALIGNANCY_PLACEHOLDER]. Additional findings: mild bilateral sacroiliac and bilateral knee joint uptake pattern consistent with degenerative osteoarthritis — non-specific.
Clinical Correlation and Recommendation: Correlation with MRI of the lumbar spine with and without contrast is recommended per SNMMI bone scan reporting guidelines to differentiate compression fracture from metastatic involvement at L4. Attending physician Dr. [PHYSICIAN_NAME] verbally notified of findings at [NOTIFICATION_TIME] and agrees with recommendation for MRI correlation. This addendum documents the L4 finding and clinical recommendation — no change to prior scan interpretation.
Document 2 — RAI-131 Radiation Precautions Handout:
RADIATION SAFETY PRECAUTIONS — RAI-131 ABLATION DISCHARGE INSTRUCTIONS
Facility: [FACILITY_NAME] Nuclear Medicine Department | Technologist: [TECH_NAME], CNMT
Physician: Dr. [PHYSICIAN_NAME] | Date of Treatment: [TREATMENT_DATE_PLACEHOLDER]
You have received Radioiodine-131 (I-131) for treatment of your thyroid condition. I-131 emits radiation that will decrease over time (physical half-life: 8.02 days). To protect your family and others, please follow these precautions carefully for the next [ISOLATION_DAYS] days.
DISTANCE AND CONTACT: Stay at least 6 feet away from others when possible. Avoid prolonged close contact (within 3 feet for more than 1 hour) with children under 18 or pregnant women for [CHILD_CONTACT_DAYS] days — their developing tissues are more sensitive to radiation exposure. Sleep in a separate room from your spouse or partner for [SLEEP_SEPARATE_DAYS] nights.
HOUSEHOLD PRECAUTIONS: Use separate utensils, dishes, and towels. Launder your clothing and bedding separately from household items. Flush the toilet twice after each use. Wash hands thoroughly with soap and water after using the bathroom.
WORK AND TRAVEL: [RETURN_TO_WORK_PLACEHOLDER] — if your job involves close contact with the public, children, or pregnant coworkers, contact our office for specific guidance. Carry your NRC release document ([RELEASE_DOCUMENT_PLACEHOLDER]) for [CARRY_DOCUMENT_DAYS] days — radiation detectors at airports and government buildings may detect residual I-131. These precautions follow ALARA (As Low As Reasonably Achievable) principles per NRC regulations 10 CFR 35.75. Questions? Call our department at [DEPARTMENT_PHONE_PLACEHOLDER].
Document 3 — Gamma Camera QC Failure Log:
GAMMA CAMERA UNIFORMITY QC FAILURE LOG
Camera: [CAMERA_MODEL_PLACEHOLDER] | QC Date: [QC_DATE] | Technologist: [TECH_NAME], CNMT
Daily uniformity QC performed per SNMMI equipment performance standards and departmental SOP. QC source: [QC_SOURCE_PLACEHOLDER] (e.g., Co-57 flood source / intrinsic point source).
QC RESULT — FAIL:
Center Field of View (CFOV) Integral Uniformity: [CFOV_RESULT]% (threshold ≤5.0% — EXCEEDED)
Differential Uniformity (CFOV): [DFOV_RESULT]% (threshold ≤3.0% — [PASS/FAIL_PLACEHOLDER])
Immediate Action: Camera placed OUT OF SERVICE for patient imaging effective [OUT_OF_SERVICE_TIME]. All scheduled patient studies on this camera suspended. Supervising physician Dr. [PHYSICIAN_NAME] notified at [NOTIFICATION_TIME]. Physics/biomedical engineering service call initiated — service technician [SERVICE_TECH_PLACEHOLDER] contacted via [CONTACT_METHOD] at [SERVICE_CALL_TIME].
Patient Impact: [PATIENT_COUNT_PLACEHOLDER] scheduled studies affected. Cases rescheduled per departmental protocol or routed to [ALTERNATE_CAMERA_PLACEHOLDER] pending repair resolution. Estimated camera return to service: [ESTIMATED_RESOLUTION].
Documentation: QC failure logged in equipment maintenance record per SNMMI QC standards. Camera returned to service requires passing uniformity QC before patient imaging resumes. Supervisor sign-off: [SUPERVISOR_PLACEHOLDER].
⭐ Most Popular
AI Prompt Bible — $17
1,000+ prompts for every nuclear medicine documentation, QC reporting, protocol writing, and career development scenario CNMTs face. The AI Prompt Bible is what imaging professionals use to clear the documentation queue without staying late on QC failure days.
Get The AI Prompt Bible — $17 →How Much Time Can ChatGPT Save Nuclear Medicine Technologists?
These numbers reflect what happens when you replace blank-page writing with structured prompt-to-draft workflows — same documentation quality, fraction of the time.
| Task | Manual | With ChatGPT | Time Savings |
|---|---|---|---|
| Scan report addendum | 18–25 min | 4–6 min | ~76% |
| Patient education handout (RAI) | 15–20 min | 4–5 min | ~75% |
| QC failure narrative | 20–28 min | 5–7 min | ~74% |
| Protocol deviation documentation | 22–30 min | 5–7 min | ~77% |
| Competency assessment documentation | 18–25 min | 5–7 min | ~73% |
Across 10–14 scans per shift and NRC compliance documentation sprints, the queue adds up fast. Finish your shift instead of drowning in paperwork.
35 ChatGPT Prompts for Nuclear Medicine Technologists & CNMTs
Use these as-is or customize the variables in brackets. Every prompt is designed to generate a complete, ready-to-review draft on the first try. Use placeholders only — never real patient data, dose calibrator readings, or NRC license information — in every prompt. All QC documentation, deviation reports, patient education materials, and protocol documents must be reviewed and approved by your supervising nuclear medicine physician and radiation safety officer before use.
Section 1Scan Documentation & Report Addendums
Nuclear medicine technologists generate detailed documentation for every scan they perform — radiopharmaceutical dose verification, patient preparation notes, acquisition protocol documentation, and report addendums when technologist observations need to be communicated to the interpreting physician. With 10–14 scans per day across bone scans, cardiac stress tests, thyroid uptakes, and PET/CT studies, documentation falls behind fast. These 7 prompts generate complete scan documentation, report addendums, and radiopharmaceutical administration records for the full range of NMT workflow scenarios. Use placeholder variables only — never enter real patient identifiers, dose calibrator readings, or PHI into ChatGPT. All report addendums must be reviewed by the supervising nuclear medicine physician before being added to the final report.
1Bone Scan Report Addendum — Focal Uptake Finding
Write a formal bone scan (Tc-99m MDP) report addendum documenting an unexpected focal uptake finding that requires clinical correlation. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME] nuclear medicine department. Accession: [ACCESSION_PLACEHOLDER].
Radiopharmaceutical: Technetium-99m methylene diphosphonate (Tc-99m MDP), [DOSE_MCI] mCi IV administered at [ADMINISTRATION_TIME]. Acquisition protocol: [ACQUISITION_TYPE] (e.g., whole body planar and SPECT/CT of the region of interest; 3-phase study — dynamic flow phase, blood pool phase at 5 minutes, delayed images at 3 hours post-injection).
Focal finding: [ANATOMIC_LOCATION_PLACEHOLDER] (e.g., L4 vertebral body, right 7th rib, left femoral neck) — [UPTAKE_DESCRIPTION] (e.g., focal increased radiotracer uptake on delayed images; abnormal 3-phase uptake pattern; photopenic defect with peripheral rim activity). Differential consideration: [DIFFERENTIAL_PLACEHOLDER] (e.g., compression fracture with associated hyperemia vs. metastatic lesion given clinical history of [PRIMARY_MALIGNANCY_PLACEHOLDER]; osteoid osteoma vs. stress fracture; post-surgical change vs. hardware loosening).
Addendum purpose: Document finding and recommend clinical correlation with [RECOMMENDED_IMAGING_PLACEHOLDER] (e.g., MRI with and without contrast, CT of the region) per SNMMI bone scan reporting guidelines. Attending physician Dr. [PHYSICIAN_NAME] notified at [NOTIFICATION_TIME]. Write approximately 150–175 words in formal nuclear medicine report addendum format.2Whole Body Bone Scan Documentation — Normal Study
Write documentation for a normal whole body bone scan study. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME].
Radiopharmaceutical: Tc-99m MDP (technetium-99m methylene diphosphonate), [DOSE_MCI] mCi intravenously administered at [ADMINISTRATION_TIME]. Patient preparation confirmed: [PREP_STATUS] (e.g., patient well-hydrated, voided prior to imaging, no recent barium studies, no recent nuclear medicine studies within [DAYS] days per departmental protocol).
Acquisition: Whole body planar imaging (anterior and posterior) acquired at [TIME_POST_INJECTION] hours post-injection on [CAMERA_MODEL_PLACEHOLDER]. Additional SPECT or SPECT/CT performed of [SPECT_REGION_PLACEHOLDER] if applicable. Imaging duration: [SCAN_DURATION] minutes. Patient positioning: supine, arms at sides. Motion noted: [MOTION_STATUS_PLACEHOLDER].
Technologist observation note: Symmetric, homogeneous radiotracer distribution throughout the axial and appendicular skeleton. No focal areas of abnormal increased or decreased radiotracer uptake identified by the technologist on review. Incidental soft tissue uptake noted at [INCIDENTAL_FINDING_PLACEHOLDER] if applicable. Images submitted to interpreting physician Dr. [PHYSICIAN_NAME] for final interpretation. Write approximately 130–155 words in scan documentation record format consistent with SNMMI practice standards.3Myocardial Perfusion SPECT Report Addendum — Equivocal Finding
Write a report addendum for an equivocal perfusion defect on a stress/rest Tc-99m sestamibi myocardial perfusion SPECT study. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME].
Study details: Tc-99m sestamibi (technetium-99m methoxyisobutylisonitrile) two-day stress/rest myocardial perfusion SPECT protocol. Stress dose: [STRESS_DOSE_MCI] mCi administered at peak stress ([STRESS_TYPE_PLACEHOLDER] — e.g., treadmill Bruce protocol, pharmacologic vasodilator stress with [AGENT_PLACEHOLDER]). Rest dose: [REST_DOSE_MCI] mCi administered at [REST_ADMIN_TIME]. Camera: [CAMERA_MODEL_PLACEHOLDER]. SPECT acquisition: [ACQUISITION_PARAMETERS_PLACEHOLDER] (e.g., 64 projections, 180-degree acquisition, step-and-shoot, 20 seconds per frame).
Equivocal finding: [PERFUSION_DESCRIPTION] (e.g., mild-to-moderate fixed defect in the [TERRITORY_PLACEHOLDER] — inferior wall — present on both stress and rest images; fixed defect may represent artifact [diaphragmatic attenuation], scar, or hibernating myocardium; stress-induced defect in the [TERRITORY_PLACEHOLDER] not clearly resolved on rest imaging). Gating data: [GATING_STATUS_PLACEHOLDER] (e.g., gated SPECT performed — LVEF [VALUE]%, wall motion [DESCRIPTION_PLACEHOLDER]). Technologist addendum: Equivocal finding in [TERRITORY_PLACEHOLDER] documented. Attenuation correction [PERFORMED/NOT_PERFORMED_PLACEHOLDER]. Prone imaging [PERFORMED/NOT_PERFORMED_PLACEHOLDER]. Dr. [PHYSICIAN_NAME] notified at [NOTIFICATION_TIME]. Write approximately 155–175 words in formal nuclear medicine report addendum format.4PET/CT Scan Documentation — FDG Administration Record
Write an FDG-18 (fluorodeoxyglucose F-18) administration and acquisition documentation record for an oncology PET/CT study. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME] PET/CT suite.
Radiopharmaceutical: F-18 FDG (fluorodeoxyglucose F-18), [DOSE_MCI] mCi ([DOSE_MBQ_PLACEHOLDER] MBq). Lot number: [LOT_NUMBER_PLACEHOLDER]. Calibration time: [CALIBRATION_TIME]. Administered activity (post-decay-corrected): [ADMIN_ACTIVITY_MCI] mCi at [ADMIN_TIME]. Route: intravenous, [INJECTION_SITE_PLACEHOLDER]. Extravasation: [EXTRAVASATION_STATUS] (none noted / suspected — see deviation note). Dose calibrator reading: [CALIBRATOR_READING_PLACEHOLDER] — acceptable within [ACCEPTABLE_RANGE_PLACEHOLDER]% of ordered dose per departmental protocol.
Patient preparation: Fasting for [FAST_DURATION] hours confirmed. Pre-injection blood glucose: [GLUCOSE_VALUE_PLACEHOLDER] mg/dL ([GLUCOSE_STATUS_PLACEHOLDER] — acceptable per departmental protocol threshold of [THRESHOLD_PLACEHOLDER] mg/dL; imaging proceeded / deferred — [REASON_PLACEHOLDER]). Uptake time: [UPTAKE_TIME] minutes in quiet, low-light environment with patient at rest. Hydration: [HYDRATION_STATUS_PLACEHOLDER].
Acquisition: PET/CT whole body, vertex to mid-thigh, acquired on [PET_CT_SCANNER_PLACEHOLDER]. Scan direction: [DIRECTION_PLACEHOLDER]. CT: [CT_PARAMETERS_PLACEHOLDER] (e.g., low-dose attenuation correction CT; diagnostic CT with [CONTRAST_STATUS_PLACEHOLDER]). PET: [BED_POSITIONS_PLACEHOLDER] bed positions, [TIME_PER_BED_PLACEHOLDER] minutes per bed. Reconstruction: [RECONSTRUCTION_PROTOCOL_PLACEHOLDER]. Write approximately 175–200 words in PET/CT administration and acquisition documentation format.5Thyroid Uptake & Scan Report Documentation — RAI-123 Study
Write documentation for a radioiodine-123 (I-123) thyroid uptake and scan study. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME].
Radiopharmaceutical: Sodium Iodide I-123, [DOSE_MICROCURIE_PLACEHOLDER] microcuries ([DOSE_MCI] mCi) administered orally at [ADMIN_TIME] on [ADMIN_DATE]. Patient preparation confirmed: no iodine-containing contrast within [CONTRAST_WASHOUT_WEEKS] weeks; no thyroid medications for [MED_HOLD_DAYS] days (TSH stimulation achieved — [TSH_VALUE_PLACEHOLDER] mIU/L); dietary iodine restriction confirmed for [DIET_DAYS] days per departmental protocol.
4-hour uptake measurement: Performed at [FOUR_HR_TIME]. Thyroid uptake: [FOUR_HR_VALUE_PLACEHOLDER]% (normal reference range for this facility: [FOUR_HR_RANGE_PLACEHOLDER]%). Neck background corrected. Thyroid phantom used: [PHANTOM_PLACEHOLDER].
24-hour uptake measurement: Performed at [TWENTY_FOUR_HR_TIME]. Thyroid uptake: [TWENTY_FOUR_HR_VALUE_PLACEHOLDER]% (normal reference range: [TWENTY_FOUR_HR_RANGE_PLACEHOLDER]%). Thyroid scan images acquired: anterior, right anterior oblique, and left anterior oblique projections. Camera: [CAMERA_MODEL_PLACEHOLDER] with low-energy, high-resolution collimator. Marker placed at [MARKER_LOCATION_PLACEHOLDER] for anatomic reference. Technologist observation: [SCAN_OBSERVATION_PLACEHOLDER] (e.g., homogeneous diffuse uptake pattern consistent with diffuse goiter; focal areas of increased or decreased uptake in [LOBE_PLACEHOLDER]; enlarged gland with irregular uptake pattern). Images submitted to Dr. [PHYSICIAN_NAME] for interpretation. Write approximately 150–175 words in thyroid uptake and scan documentation format.6Radiopharmaceutical Dose Administration Record
Write a complete radiopharmaceutical dose administration record with dose calibrator readings. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Facility: [FACILITY_NAME] nuclear medicine department. Date: [ADMIN_DATE].
Patient identifiers used for verification: [TWO_IDENTIFIER_PLACEHOLDER] (e.g., name and date of birth; name and medical record number — two identifiers confirmed against requisition per departmental protocol and NRC requirements before administration).
Radiopharmaceutical: [RP_NAME_PLACEHOLDER] (e.g., Tc-99m MDP, Tc-99m sestamibi, F-18 FDG, I-123 NaI, Tc-99m MAA). Lot/vial number: [LOT_NUMBER_PLACEHOLDER]. Calibration time and date: [CALIBRATION_TIME] on [CALIBRATION_DATE]. Ordered dose: [ORDERED_DOSE_MCI] mCi. Dose calibrator assay time: [ASSAY_TIME]. Measured activity at assay time: [MEASURED_ACTIVITY_MCI] mCi. Decay-corrected activity at time of administration: [DECAY_CORRECTED_ACTIVITY_MCI] mCi at [ADMIN_TIME].
Acceptable dose range per departmental protocol: [DOSE_RANGE_PLACEHOLDER] mCi. Dose within acceptable range: [YES/NO_PLACEHOLDER]. Route of administration: [ROUTE_PLACEHOLDER] (e.g., intravenous, oral, intradermal). Injection site: [INJECTION_SITE_PLACEHOLDER]. Extravasation suspected: [EXTRAVASATION_STATUS_PLACEHOLDER]. Adverse reaction: [ADVERSE_REACTION_PLACEHOLDER] (e.g., none observed; see incident report [INCIDENT_NUMBER_PLACEHOLDER]). Time of administration: [ADMIN_TIME]. Technologist signature: [TECH_NAME], CNMT. Write approximately 150–175 words in formal radiopharmaceutical administration record format consistent with NRC 10 CFR 35 requirements.7Sentinel Lymph Node Mapping Documentation — Tc-99m Sulfur Colloid
Write documentation for a lymphoscintigraphy and sentinel lymph node (SLN) mapping procedure using Tc-99m sulfur colloid. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Surgeon: Dr. [SURGEON_NAME_PLACEHOLDER]. Facility: [FACILITY_NAME].
Procedure: Sentinel lymph node mapping, [PRIMARY_SITE_PLACEHOLDER] (e.g., breast, melanoma — right upper outer quadrant; left lower extremity). Radiopharmaceutical: Tc-99m sulfur colloid (filtered, [FILTER_SIZE_PLACEHOLDER] micron filter), [TOTAL_DOSE_MCI] mCi divided into [NUMBER_INJECTIONS_PLACEHOLDER] intradermal/peritumoral injections of [DOSE_PER_INJECTION_MCI] mCi each. Administration time: [ADMIN_TIME]. Injection sites: [INJECTION_SITE_DESCRIPTION_PLACEHOLDER]. Injection performed by: [INJECTING_PROVIDER_PLACEHOLDER].
Dynamic imaging: Obtained immediately post-injection, [DYNAMIC_DURATION_PLACEHOLDER] minutes, [FRAMES_PER_SECOND_PLACEHOLDER] seconds per frame, demonstrating [LYMPHATIC_FLOW_DESCRIPTION_PLACEHOLDER] (e.g., prompt lymphatic flow to axillary nodal basin; delayed drainage; no flow visualized — see note). Static images acquired at [STATIC_IMAGE_TIMES_PLACEHOLDER] hours post-injection: anterior and [ADDITIONAL_VIEWS_PLACEHOLDER] projections. SPECT/CT performed: [SPECT_CT_STATUS_PLACEHOLDER].
Sentinel node(s) identified: [NODE_COUNT_PLACEHOLDER] node(s) in [NODAL_BASIN_PLACEHOLDER] (e.g., left axilla, right inguinal, internal mammary). Skin surface marked with [MARKING_METHOD_PLACEHOLDER] at time of imaging. Surgeon Dr. [SURGEON_NAME_PLACEHOLDER] notified of sentinel node location(s) at [NOTIFICATION_TIME]. Intraoperative gamma probe use: [PROBE_STATUS_PLACEHOLDER]. Write approximately 165–190 words in lymphoscintigraphy procedure documentation format.Section 2Patient Education & Radiation Safety Communications
Patient education in nuclear medicine is uniquely complex — patients receive radioactive materials, and what they do after leaving the department directly affects their family members' radiation exposure. NRC regulations require written radiation safety instructions for patients released with administered activities above certain thresholds. These 7 prompts generate complete patient education handouts, radiation precaution instructions, pre-procedure preparation guides, and post-procedure safety communications for the full range of nuclear medicine studies. All patient-facing materials must be reviewed by the supervising nuclear medicine physician and must comply with your facility's NRC license and radiation safety program before distribution.
8RAI-131 Post-Ablation Radiation Precautions — Patient Handout
Write radiation precaution instructions for a patient being discharged after therapeutic I-131 (radioiodine-131) ablation. Use de-identified placeholders only — no real patient names, MRNs, or dose-specific PHI. Facility: [FACILITY_NAME] nuclear medicine department. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME].
Procedure context: Patient received I-131 sodium iodide for [INDICATION_PLACEHOLDER] (e.g., differentiated thyroid cancer post-thyroidectomy, hyperthyroidism). Administered activity: [RAI_DOSE_MCI] mCi. NRC release criteria met: administered activity < 33 mCi OR measured exposure rate ≤ 7 mrem/hr at 1 meter — per NRC 10 CFR 35.75. Effective half-life: approximately [EFFECTIVE_HALFLIFE_DAYS] days.
NRC-required precautions for home isolation period ([ISOLATION_DAYS] days):
- Maintain ≥6 feet distance from others when possible
- Sleep separately from spouse or partner for [SLEEP_SEPARATE_DAYS] nights
- Avoid close contact (within 3 feet for >1 hour) with children and pregnant women for [CHILD_CONTACT_DAYS] days
- Flush toilet twice after each use; wash hands thoroughly with soap and water
- Use separate utensils, dishes, and towels; launder clothing and bedding separately
- Return to work: [RETURN_TO_WORK_PLACEHOLDER] (job-dependent — contact department for guidance if close public contact or pregnant coworkers involved)
- Carry NRC release document ([RELEASE_DOCUMENT_PLACEHOLDER]) for [CARRY_DOCUMENT_DAYS] days for airport and security detector purposes
Write approximately 200–225 words in plain-language patient education handout format. Reference ALARA principle and NRC regulations 10 CFR 35.75. Include a department contact number placeholder [DEPARTMENT_PHONE_PLACEHOLDER].9Bone Scan Pre-Procedure Instructions — Patient Handout
Write pre-procedure instructions for a patient scheduled for a Tc-99m MDP whole body bone scan. Use de-identified placeholders only. Facility: [FACILITY_NAME] nuclear medicine department.
Instructions to cover: (1) What the test is — bone scan uses a small amount of a radioactive tracer (Tc-99m MDP) that is absorbed by bone; the camera takes pictures of the tracer distribution to identify areas of abnormal bone activity; the amount of radiation received is low and comparable to standard CT scan levels, (2) No special dietary restrictions required unless ordered by your physician — normal medications may be taken unless instructed otherwise by Dr. [PHYSICIAN_NAME], (3) Hydration — drink [HYDRATION_AMOUNT_PLACEHOLDER] ounces of water in the [HYDRATION_WINDOW_PLACEHOLDER] hours before your appointment and continue drinking water throughout the waiting period; adequate hydration improves image quality and helps clear tracer from soft tissues, (4) Appointment structure — you will receive an injection of the tracer, wait [UPTAKE_TIME_PLACEHOLDER] hours (typically 2–4 hours), then return for imaging; total visit time approximately [TOTAL_VISIT_PLACEHOLDER] hours; bring something to read or listen to, (5) Void before imaging — you will be asked to empty your bladder immediately before getting on the camera table; a full bladder can obscure pelvic structures, (6) Metal objects and clothing — wear comfortable, loose clothing; remove metal objects (belt buckles, keys, jewelry) before imaging; no IV contrast required, (7) Post-procedure — no restrictions after the scan; residual tracer leaves the body primarily through urine over [CLEARANCE_DAYS_PLACEHOLDER] days; continue drinking water; no radiation precautions required for routine diagnostic doses. Write approximately 200–225 words in patient-friendly handout format.10Cardiac Stress Test (SPECT) Patient Preparation Instructions
Write preparation instructions for a patient scheduled for a myocardial perfusion SPECT (nuclear stress test) study using Tc-99m sestamibi or Tc-99m tetrofosmin. Use de-identified placeholders only. Facility: [FACILITY_NAME] nuclear medicine department. Ordering Physician: Dr. [PHYSICIAN_NAME].
Instructions to cover: (1) Medications to hold — [HOLD_MEDICATIONS_PLACEHOLDER]: beta-blockers ([HOLD_HOURS_PLACEHOLDER] hours before stress, unless contraindicated — confirm with Dr. [PHYSICIAN_NAME]); calcium channel blockers — [HOLD_HOURS_PLACEHOLDER] hours; nitrates — [HOLD_HOURS_PLACEHOLDER] hours; caffeine (coffee, tea, chocolate, caffeinated medications) — 24 hours before if pharmacologic stress is used with dipyridamole or adenosine; (2) Fasting — nothing to eat or drink (except water and essential medications) for [FAST_HOURS_PLACEHOLDER] hours before your appointment; (3) Comfortable clothing — wear or bring comfortable walking shoes and loose-fitting two-piece clothing; you may be connected to an EKG monitor and IV line; (4) What to expect — Day 1 (or same-day two-injection protocol): you will receive an injection and exercise on a treadmill (or receive a pharmacologic stress medication if treadmill is not appropriate); imaging follows approximately [DELAY_PLACEHOLDER] minutes post-stress injection; rest imaging will be performed [REST_TIMING_PLACEHOLDER] (same day or following day depending on protocol); (5) Duration — total visit time approximately [TOTAL_TIME_PLACEHOLDER] hours; plan accordingly; (6) Accompaniment — you may bring a support person; depending on medications administered, you may be advised not to drive for [DRIVE_RESTRICTION_PLACEHOLDER] hours. Write approximately 200–225 words in patient education format, plain language.11PET/CT Pre-Procedure Instructions — FDG Oncology Study
Write patient preparation instructions for an FDG PET/CT oncology scan. Use de-identified placeholders only. Facility: [FACILITY_NAME] PET/CT center. Ordering Physician: Dr. [PHYSICIAN_NAME].
Instructions to cover: (1) Fasting — no food or beverages except water for [FAST_HOURS_PLACEHOLDER] hours before your appointment; fasting is critical because elevated blood glucose competes with FDG uptake and can reduce image quality or cause a scan to be rescheduled; (2) Diabetic patients — [DIABETIC_INSTRUCTIONS_PLACEHOLDER]: if you take insulin or oral hypoglycemic medications, special instructions will be provided; contact our department at [DEPARTMENT_PHONE_PLACEHOLDER] to review your specific diabetes management plan before the day of your scan; (3) No strenuous exercise for [EXERCISE_HOLD_DAYS_PLACEHOLDER] days before the scan — exercise increases glucose uptake in muscles, which can interfere with interpretation; (4) Hydration — drink [HYDRATION_AMOUNT_PLACEHOLDER] ounces of plain water in the hours before your appointment; avoid sugary drinks, juice, or flavored waters; (5) Medications — take your regular medications with a small amount of water unless instructed otherwise by Dr. [PHYSICIAN_NAME]; (6) Blood glucose check — your blood glucose will be checked upon arrival; if glucose is above [GLUCOSE_THRESHOLD_PLACEHOLDER] mg/dL, your scan may need to be rescheduled to obtain diagnostic-quality images; (7) What to expect — you will receive an FDG injection, rest quietly for [UPTAKE_TIME_PLACEHOLDER] minutes (this uptake period is essential — please avoid movement and conversation), then proceed to the PET/CT scanner; total visit approximately [TOTAL_VISIT_PLACEHOLDER] hours; (8) Radiation — the FDG used is low-level radiation; no special precautions required after routine diagnostic imaging. Write approximately 225–250 words in plain-language patient education format.12Radiation Safety FAQ for Patients After Diagnostic Nuclear Medicine Studies
Write a FAQ document answering common patient questions about radiation safety after routine diagnostic nuclear medicine scans (bone scan, thyroid uptake, cardiac SPECT — standard diagnostic doses). Use de-identified placeholders only. Facility: [FACILITY_NAME] nuclear medicine department.
Include answers to the following questions in plain language:
Q1: How much radiation did I receive from this scan?
Answer: Compare to familiar references — annual background radiation, chest X-ray equivalent, cross-country flight.
Q2: Is it safe to be around my children and family after a bone scan or cardiac scan?
Answer: For standard diagnostic doses (bone scan, cardiac SPECT, thyroid uptake), briefly explain why precautions are typically not required vs. therapeutic I-131 where they are.
Q3: How long will the radioactive material stay in my body?
Answer: Explain physical half-life vs. effective half-life; typical clearance times for common agents (Tc-99m: ~6-hour physical half-life, cleared via kidneys in 24 hours; I-123: [I123_HALFLIFE_PLACEHOLDER]-hour physical half-life).
Q4: Can I breastfeed after my scan?
Answer: Address that breastfeeding guidance is radiopharmaceutical-specific; for Tc-99m agents, pumping and discarding for [BREASTFEED_HOLD_PLACEHOLDER] hours is standard; for I-123 and I-131, longer interruptions are required per NRC guidance; always confirm with the nuclear medicine physician.
Q5: Will airport security scanners detect the radiation from my scan?
Answer: Yes — Tc-99m and other agents can trigger radiation portal monitors for days after the scan; carry your NRC/facility documentation.
Q6: Do I need to take any special precautions or change my diet?
Answer: Standard diagnostic doses require no dietary restrictions, no isolation.
Write approximately 300–350 words in FAQ format with bolded questions and plain-language paragraph answers.13Thyroid RAI-131 Therapy Pre-Treatment Patient Consent Education
Write patient education material explaining the RAI-131 (radioiodine-131) ablation procedure to a patient prior to treatment. This is pre-treatment education to support informed consent — not a substitute for the physician consent process. Use de-identified placeholders only. Facility: [FACILITY_NAME]. Supervising Physician: Dr. [PHYSICIAN_NAME].
Cover the following in patient-friendly language: (1) What RAI-131 is — radioactive iodine that the thyroid (or thyroid remnant) naturally absorbs; the radiation destroys thyroid tissue; used for [INDICATION_PLACEHOLDER] (e.g., differentiated thyroid cancer post-thyroidectomy, hyperthyroidism), (2) How the treatment is given — swallowed as a capsule or liquid; [ADMIN_SETTING_PLACEHOLDER] (outpatient if dose below NRC threshold; inpatient hospitalization if dose requires it); the entire procedure takes approximately [PROCEDURE_DURATION_PLACEHOLDER], (3) TSH stimulation preparation — [TSH_PREP_PLACEHOLDER]: thyroid hormone withdrawal ([THW_DURATION_PLACEHOLDER] weeks off thyroid medication) OR recombinant human TSH (Thyrogen) injections — your physician will specify which applies to you, (4) Low-iodine diet — required for [DIET_DURATION_PLACEHOLDER] days before treatment to maximize thyroid remnant uptake of I-131; foods to avoid: iodized salt, dairy, seafood, cured meats, some breads, (5) What happens after treatment — radiation precautions are required at home for [ISOLATION_DAYS_PLACEHOLDER] days per NRC regulations (distance from others, sleeping separately, handwashing, separate utensils); you will receive written discharge instructions, (6) Expected side effects — [SIDE_EFFECTS_PLACEHOLDER] (e.g., temporary neck tenderness or swelling over the thyroid remnant; nausea in first 24–48 hours; sialadenitis — salivary gland inflammation — sour candies and hydration can help; fatigue; hypothyroidism — thyroid hormone replacement will be adjusted by Dr. [PHYSICIAN_NAME]), (7) Follow-up — [FOLLOWUP_PLACEHOLDER] (e.g., whole body scan [WBS_TIMING_PLACEHOLDER] days post-ablation; thyroglobulin levels; thyroid hormone dose adjustment). Write approximately 275–325 words in patient education format.14Pediatric Nuclear Medicine Study Parent Education Handout
Write a parent education handout for a child scheduled for a pediatric nuclear medicine study. Use de-identified placeholders only. Facility: [FACILITY_NAME] nuclear medicine / pediatric radiology department. Physician: Dr. [PHYSICIAN_NAME].
Study type: [STUDY_TYPE_PLACEHOLDER] (e.g., Tc-99m MAG3 renal scan, Tc-99m DMSA renal cortical scan, Tc-99m bone scan for pediatric limping child, Tc-99m HMPAO brain perfusion SPECT). Pediatric patient age: [PATIENT_AGE_PLACEHOLDER] (child's age determines dose — weight-based dosing per SNMMI/EANM pediatric dosage card).
Cover the following for parents: (1) What the study does and why it was ordered — [STUDY_PURPOSE_PLACEHOLDER] in child-appropriate and parent-appropriate language; emphasize clinical value and why this study answers questions that anatomic imaging (X-ray, ultrasound) cannot, (2) Radiation dose — pediatric doses are weight-based and calculated to minimize radiation exposure per ALARA principle; the dose your child will receive is [DOSE_DESCRIPTION_PLACEHOLDER]; compare to naturally occurring background radiation for context, (3) Preparation — [PREP_INSTRUCTIONS_PLACEHOLDER] (e.g., hydration instructions, voiding schedule for renal studies, fasting if sedation is required, hold any medications — confirm with Dr. [PHYSICIAN_NAME]), (4) What to expect on the day — injection of the tracer ([INJECTION_DESCRIPTION_PLACEHOLDER] — small amount through IV or topical numbing cream available); waiting period of [WAIT_TIME_PLACEHOLDER]; camera imaging with your child lying still for [IMAGING_DURATION_PLACEHOLDER] minutes; you may stay with your child during imaging in most cases, (5) Sedation — [SEDATION_STATUS_PLACEHOLDER] (required / not required for this study — if required, separate sedation consent and NPO instructions will be provided), (6) After the study — [POST_STUDY_PLACEHOLDER]: encourage fluids and normal urination to help clear the tracer; no restrictions on contact with siblings unless specifically instructed; the small amount of radiotracer used in diagnostic studies does not require family radiation precautions. Write approximately 225–250 words in parent-friendly education format.Section 3QC Logs, Equipment Failure Reports & Corrective Actions
Nuclear medicine quality control is non-negotiable — SNMMI/EANM equipment performance standards, NRC regulatory requirements, and accreditation standards require documented daily, weekly, and monthly QC for every gamma camera, dose calibrator, and survey meter in the department. When QC fails, the camera goes out of service and a corrective action narrative goes into the log before patient imaging resumes. These 7 prompts generate complete QC failure logs, equipment performance records, corrective action narratives, and NRC-compliant documentation for the full range of nuclear medicine QC scenarios. All QC documentation must be reviewed by your supervising physician and radiation safety officer before filing.
15Gamma Camera Uniformity QC Failure — Corrective Action Log
Write a QC failure log and corrective action narrative for a gamma camera daily uniformity failure. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Camera: [CAMERA_MODEL_PLACEHOLDER]. QC Date: [QC_DATE]. Facility: [FACILITY_NAME] nuclear medicine department.
QC type: Daily intrinsic/extrinsic uniformity QC. QC source: [QC_SOURCE_PLACEHOLDER] (e.g., Co-57 flood source for extrinsic uniformity; point source for intrinsic). QC result: Center Field of View (CFOV) integral uniformity = [CFOV_RESULT]% (measured). Acceptable threshold per SNMMI equipment performance standards and departmental protocol: CFOV integral uniformity ≤5.0%. Differential uniformity (CFOV): [DFOV_RESULT]% (threshold ≤3.0% — [PASS_FAIL_PLACEHOLDER]).
Failure: CFOV integral uniformity [CFOV_RESULT]% exceeds the ≤5.0% threshold — QC FAIL. Camera placed OUT OF SERVICE for patient imaging immediately at [OUT_OF_SERVICE_TIME].
Corrective action: Supervising physician Dr. [PHYSICIAN_NAME] notified at [NOTIFICATION_TIME]. All scheduled patient studies on this camera suspended pending resolution. Physics/biomedical engineering service call initiated — service technician [SERVICE_TECH_PLACEHOLDER] contacted via [CONTACT_METHOD] at [SERVICE_CALL_TIME]. Potential causes investigated: [CAUSE_INVESTIGATION_PLACEHOLDER] (e.g., PMT gain drift, flood source position, crystal damage, collimator condition).
Patient impact: [PATIENT_COUNT_PLACEHOLDER] scheduled studies affected. Cases rescheduled per departmental protocol or routed to [ALTERNATE_CAMERA_PLACEHOLDER] pending repair. Estimated camera return to service: [ESTIMATED_RESOLUTION].
Documentation: QC failure logged in equipment maintenance record. Camera may not be returned to patient service until passing uniformity QC is documented. Supervisor sign-off: [SUPERVISOR_PLACEHOLDER]. Write approximately 175–200 words in QC failure log format consistent with SNMMI equipment QC standards.16Dose Calibrator QC Failure Documentation
Write QC failure documentation for a dose calibrator accuracy or linearity failure. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Facility: [FACILITY_NAME]. Dose Calibrator Model: [CALIBRATOR_MODEL_PLACEHOLDER]. QC Date: [QC_DATE].
QC type: [QC_TYPE_PLACEHOLDER] — select one: (a) Accuracy test — using [STANDARD_SOURCE_PLACEHOLDER] (e.g., Cs-137 or Co-57 certified reference standard, [REFERENCE_ACTIVITY_MCI] mCi certified activity at [CERT_DATE]); measured activity: [MEASURED_ACTIVITY_MCI] mCi; acceptable range: within ±[ACCURACY_TOLERANCE_PLACEHOLDER]% of certified value per 10 CFR 35.60 and departmental protocol; result: [PASS_FAIL_PLACEHOLDER] — measured value [PERCENTAGE_DEVIATION_PLACEHOLDER]% from certified. (b) Linearity test — performed using [LINEARITY_METHOD_PLACEHOLDER] (e.g., Tc-99m decay series or attenuator sleeve method); linearity acceptable within ±[LINEARITY_TOLERANCE_PLACEHOLDER]% across the clinical use range ([DOSE_RANGE_PLACEHOLDER] mCi); result: [PASS_FAIL_PLACEHOLDER] — deviation of [MAX_DEVIATION_PLACEHOLDER]% observed at [ACTIVITY_LEVEL_PLACEHOLDER] mCi level.
Immediate action: Dose calibrator taken out of service for patient radiopharmaceutical assay. All patient dose measurements suspended. Supervising physician Dr. [PHYSICIAN_NAME] and Radiation Safety Officer [RSO_PLACEHOLDER] notified at [NOTIFICATION_TIME] per NRC 10 CFR 35.60 requirements.
Corrective action: [CORRECTIVE_ACTION_PLACEHOLDER] (e.g., service call initiated to [BIOMEDICAL_SERVICE_PLACEHOLDER]; recalibration and QC repeat scheduled for [REPEAT_DATE]; instrument replaced with backup calibrator [BACKUP_MODEL_PLACEHOLDER] — backup QC passed on [BACKUP_QC_DATE]).
All patient radiopharmaceutical doses administered during [AFFECTED_PERIOD_PLACEHOLDER] should be reviewed per RSO guidance. Write approximately 165–185 words in NRC-compliant dose calibrator QC failure documentation format.17Survey Meter Calibration Failure Documentation
Write documentation for a Geiger-Mueller (GM) survey meter or ionization chamber failing its annual calibration requirement. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Radiation Safety Officer: [RSO_PLACEHOLDER]. Facility: [FACILITY_NAME]. Date: [QC_DATE].
Instrument: [METER_MODEL_PLACEHOLDER] (e.g., Victoreen [MODEL], Ludlum [MODEL], Fluke Biomedical [MODEL]). Serial number: [SERIAL_NUMBER_PLACEHOLDER]. Last calibration date: [LAST_CAL_DATE]. Calibration due date: [DUE_DATE]. Calibration performed by: [CALIBRATION_VENDOR_PLACEHOLDER] (NIST-traceable calibration laboratory).
Calibration result: [RESULT_PLACEHOLDER] — FAIL. Calibration certificate indicates [FAILURE_DESCRIPTION_PLACEHOLDER] (e.g., instrument reading [PERCENT_DEVIATION_PLACEHOLDER]% above/below true value at [ENERGY_LEVEL_PLACEHOLDER] keV; dead time excessive; response non-linear across [RANGE_PLACEHOLDER] mR/hr range; battery/electronics fault identified).
NRC/regulatory implications: Per NRC 10 CFR 35.61, survey instruments used in nuclear medicine must be calibrated at least annually using a calibrated source or sent to a calibration facility. Instrument removed from service immediately. Radiation Safety Officer [RSO_PLACEHOLDER] notified at [NOTIFICATION_TIME].
Corrective action: [CORRECTIVE_ACTION_PLACEHOLDER] (e.g., instrument sent for repair and recalibration; replacement instrument [REPLACEMENT_MODEL_PLACEHOLDER] placed in service — calibration current through [REPLACEMENT_CAL_DATE]; all survey work performed with backup instrument during repair period). Review of any surveys performed with this instrument since last passing calibration scheduled per RSO guidance. Write approximately 150–175 words in instrument calibration failure documentation format.18Radioactive Spill Report — Minor Contamination Event
Write a radioactive contamination or spill incident report for a minor radioactive material spill in the nuclear medicine department. Use de-identified placeholders only — no real NRC license numbers, employee IDs, or patient data. Technologist: [TECH_NAME], CNMT. Radiation Safety Officer: [RSO_PLACEHOLDER]. Facility: [FACILITY_NAME]. Date/Time: [INCIDENT_DATE] at [INCIDENT_TIME].
Incident description: [INCIDENT_DESCRIPTION] (e.g., Tc-99m pertechnetate solution — approximately [VOLUME_PLACEHOLDER] mL — spilled on [SURFACE_PLACEHOLDER] during radiopharmaceutical preparation in hot lab; I-131 sodium iodide capsule dropped on [SURFACE_PLACEHOLDER] during administration preparation; radiopharmaceutical syringe tip contaminated [SURFACE_PLACEHOLDER] during patient injection).
Radiopharmaceutical involved: [RP_NAME_PLACEHOLDER]. Estimated activity at time of spill: [ESTIMATED_ACTIVITY_PLACEHOLDER] mCi. Area affected: [AREA_AFFECTED_PLACEHOLDER] (e.g., hot lab preparation bench, dose calibrator area, patient injection room).
Immediate actions: (1) Area evacuated and secured — access restricted pending decontamination; (2) Contamination survey performed using [SURVEY_METER_PLACEHOLDER] — contaminated area boundaries identified as [SURVEY_RESULTS_PLACEHOLDER]; (3) Decontamination performed by [DECON_TECH_PLACEHOLDER] at [DECON_TIME] using [DECON_METHOD_PLACEHOLDER] per departmental contamination control SOP; (4) Post-decontamination survey: [POST_DECON_RESULT_PLACEHOLDER] (e.g., area released — background readings achieved; residual contamination requires additional decontamination — area remains restricted); (5) Radiation Safety Officer [RSO_PLACEHOLDER] notified at [RSO_NOTIFICATION_TIME]; (6) Personnel exposure assessment: [EXPOSURE_ASSESSMENT_PLACEHOLDER].
NRC reporting requirement assessment: [REPORTING_STATUS_PLACEHOLDER] (e.g., minor spill — below NRC reportable threshold per 10 CFR 35.3045; retained in department records). Write approximately 165–190 words in radioactive spill/contamination incident report format.19NRC Recordable Event Documentation — Misadministration Near-Miss
Write documentation for an NRC-recordable event or near-miss in radiopharmaceutical administration in the nuclear medicine department. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Radiation Safety Officer: [RSO_PLACEHOLDER]. Facility: [FACILITY_NAME]. Date: [EVENT_DATE].
Event type: [EVENT_TYPE_PLACEHOLDER] — select one: (a) Near-miss — potential misadministration identified and intercepted before administration; (b) Wrong radiopharmaceutical — [RP_INTENDED_PLACEHOLDER] intended, [RP_ADMINISTERED_PLACEHOLDER] prepared; intercepted at [INTERCEPT_POINT_PLACEHOLDER]; (c) Wrong dose — ordered dose [ORDERED_DOSE_MCI] mCi, prepared dose [PREPARED_DOSE_MCI] mCi — [PERCENTAGE_DEVIATION_PLACEHOLDER]% deviation; intercepted before administration; (d) Wrong patient — two-patient identifier check performed at [CHECK_POINT_PLACEHOLDER] identified discrepancy before administration.
Event description: [DETAILED_DESCRIPTION_PLACEHOLDER] — describe exactly what occurred, at what step in the workflow, and what mechanism identified the error. Include timeline.
Immediate action: Administration halted (if near-miss) / administration documented with deviation (if event occurred). Supervising physician Dr. [PHYSICIAN_NAME] and RSO [RSO_PLACEHOLDER] notified immediately at [NOTIFICATION_TIME]. [PATIENT_NOTIFICATION_PLACEHOLDER] (patient/referring physician notification per NRC 10 CFR 35.3045 if reportable event).
NRC reportability determination: [REPORTABILITY_PLACEHOLDER] per NRC 10 CFR 35.3045 thresholds (effective dose equivalent >5 rem, or organ dose >50 rem, or wrong individual/radiopharmaceutical/route). NRC report required by [NRC_DEADLINE_PLACEHOLDER]: [YES/NO_PLACEHOLDER].
Root cause: [ROOT_CAUSE_PLACEHOLDER]. Corrective action plan: [CORRECTIVE_ACTION_PLACEHOLDER]. Write approximately 175–200 words in NRC-compliant recordable event documentation format.20Monthly Equipment QC Summary Report — Gamma Camera
Write a monthly gamma camera performance QC summary report. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Physics Supervisor: [PHYSICIST_PLACEHOLDER]. Facility: [FACILITY_NAME]. Camera: [CAMERA_MODEL_PLACEHOLDER]. Report period: [REPORT_MONTH_PLACEHOLDER].
Daily QC summary — uniformity: [TOTAL_QC_DAYS_PLACEHOLDER] business days in reporting period. QC performed: [DAYS_PERFORMED_PLACEHOLDER] days. CFOV integral uniformity results: [PASS_COUNT_PLACEHOLDER] pass / [FAIL_COUNT_PLACEHOLDER] fail. DFOV differential uniformity results: [DFOV_PASS_PLACEHOLDER] pass / [DFOV_FAIL_PLACEHOLDER] fail. Any uniformity failures and corrective actions: [FAILURE_DETAILS_PLACEHOLDER] (e.g., QC failure on [DATE_PLACEHOLDER] — CFOV [VALUE]%; camera out of service; service call; camera returned to service [DATE] — see failure log [LOG_REFERENCE_PLACEHOLDER]).
Energy resolution / peaking: daily energy peak verification performed — all within [ENERGY_TOLERANCE_PLACEHOLDER]% of photopeak center. Any drift requiring recalibration: [ENERGY_DRIFT_PLACEHOLDER].
Weekly QC summary — spatial resolution and linearity: [WEEKLY_QC_STATUS_PLACEHOLDER] (e.g., bar phantom/line source resolution QC performed on [DATES_PLACEHOLDER]; results within acceptable range [RESOLUTION_VALUES_PLACEHOLDER] mm FWHM; linearity results [LINEARITY_VALUES_PLACEHOLDER] mm maximum deviation).
Scheduled preventive maintenance performed this month: [PM_STATUS_PLACEHOLDER] (yes — service date [PM_DATE_PLACEHOLDER]; no — next PM scheduled [NEXT_PM_DATE_PLACEHOLDER]).
Camera availability: [AVAILABILITY_PERCENTAGE_PLACEHOLDER]% uptime during reporting period. Total patient studies performed: [STUDY_COUNT_PLACEHOLDER].
Physicist/medical director review: Dr. [PHYSICIST_PLACEHOLDER] / Dr. [PHYSICIAN_NAME]. Signature: [SIGNATURE_PLACEHOLDER]. Review date: [REVIEW_DATE_PLACEHOLDER]. Write approximately 175–200 words in monthly QC summary report format.21Wipe Test / Contamination Survey Log Entry
Write a routine area wipe test and contamination survey documentation record for a nuclear medicine department. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Radiation Safety Officer: [RSO_PLACEHOLDER]. Facility: [FACILITY_NAME]. Date/Time: [SURVEY_DATE] at [SURVEY_TIME].
Contamination survey type: [SURVEY_TYPE_PLACEHOLDER] — (a) Routine wipe test survey (wipe samples collected from defined areas, counted in well counter to detect removable contamination); (b) Direct radiation survey (GM survey meter used to screen areas for fixed/removable contamination); (c) Combined wipe + direct survey per departmental protocol.
Areas surveyed: [AREAS_SURVEYED_PLACEHOLDER] — e.g., hot lab preparation bench surface, dose calibrator area, patient injection chair, camera table surface, waste container exterior, floor at designated survey points, department entry/exit points.
Wipe test methodology: Cotton swab wipes collected from [NUMBER_WIPES_PLACEHOLDER] locations. Sample area: 100 cm² per wipe. Counted in [WELL_COUNTER_PLACEHOLDER] well counter. Background count rate: [BACKGROUND_CPM_PLACEHOLDER] CPM. Release criterion: [RELEASE_CRITERION_PLACEHOLDER] CPM above background (or [DPM_THRESHOLD_PLACEHOLDER] DPM/100 cm² per [APPLICABLE_STANDARD_PLACEHOLDER]).
Results: [RESULTS_SUMMARY_PLACEHOLDER] — e.g., all wipe samples within acceptable limits; wipe at [LOCATION_PLACEHOLDER] exceeded threshold — corrective decontamination performed at [DECON_TIME]; post-decontamination wipe [POST_DECON_RESULT_PLACEHOLDER].
Direct survey results: [DIRECT_SURVEY_RESULTS_PLACEHOLDER] — all areas at background / elevated reading at [ELEVATED_LOCATION_PLACEHOLDER] mR/hr. Any areas requiring restricted access: [RESTRICTED_AREA_PLACEHOLDER]. RSO notified: [RSO_NOTIFICATION_PLACEHOLDER]. Write approximately 150–175 words in contamination survey log format consistent with NRC and SNMMI QC requirements.📱 Building a Nuclear Medicine Career Presence Online?
500 Social Media Captions — $12
Nuclear medicine technologists who post radiopharmaceutical education, SPECT/PET imaging science content, and nuclear medicine career tips on Instagram and LinkedIn build audiences quickly — imaging science has a devoted niche following. The 500 Social Media Captions pack includes a full year of ready-to-post content for healthcare and imaging science professionals.
Get 500 Social Media Captions — $12 →Section 4Protocol Development & Procedure Documentation
Nuclear medicine protocols must be documented in precise, reproducible detail — acquisition parameters, patient positioning, radiopharmaceutical doses, uptake times, and image processing steps. Every protocol update requires documentation. Every new procedure requires an SOP. Every protocol deviation requires a record. These 7 prompts generate complete procedure SOPs, protocol documentation, acquisition parameter records, and protocol deviation reports for the full range of nuclear medicine departmental documentation needs. All protocol documents must be reviewed and approved by the supervising nuclear medicine physician and medical physicist before implementation.
22Bone Scan Protocol SOP — Tc-99m MDP 3-Phase Acquisition
Write a procedure SOP for a 3-phase Tc-99m MDP bone scan acquisition. Include all sections required for a department SOP. Technologist reference: [TECH_NAME], CNMT. Facility: [FACILITY_NAME] nuclear medicine department. SOP number: [SOP_NUMBER_PLACEHOLDER]. Review date: [REVIEW_DATE_PLACEHOLDER].
Include the following SOP sections: (1) Purpose and scope — document when 3-phase bone scan is indicated vs. whole body planar only (e.g., rule out osteomyelitis, acute fracture with hyperemia assessment, joint prosthesis evaluation); (2) Radiopharmaceutical — Tc-99m methylene diphosphonate (Tc-99m MDP), adult dose [DOSE_RANGE_MCI_PLACEHOLDER] mCi IV; pediatric dose per SNMMI/EANM pediatric dosage card (weight-based); dose calibrator assay required before administration; (3) Patient preparation — adequate hydration; no recent barium studies; recent prior nuclear medicine scans within [WASHOUT_DAYS_PLACEHOLDER] days to be documented; (4) Phase 1 — Dynamic flow phase: dynamic images at [FRAME_RATE_PLACEHOLDER] seconds per frame for [FLOW_DURATION_PLACEHOLDER] seconds over region of interest, acquired immediately upon IV bolus injection; camera positioned over area of interest before injection; (5) Phase 2 — Blood pool phase: static images [BLOOD_POOL_TIME_PLACEHOLDER] minutes post-injection; anterior and posterior projections of area of interest; (6) Phase 3 — Delayed imaging: whole body planar imaging at [DELAYED_TIME_PLACEHOLDER] hours post-injection; anterior and posterior; SPECT/CT of region of interest if indicated; (7) Camera setup — [CAMERA_PARAMETERS_PLACEHOLDER]: collimator (LEHR), energy window (140 keV ± 10%), matrix size, zoom, scan speed; (8) Image processing and review — technologist reviews images before patient discharge; reports addendum to physician if incidental finding identified; (9) Documentation — dose administration record, 3-phase acquisition log, physician notification if addendum required. Write approximately 375–425 words in numbered SOP format with section headers.23Myocardial Perfusion SPECT Protocol Documentation — Rest/Stress
Write a protocol SOP for a myocardial perfusion SPECT imaging study (rest/stress Tc-99m sestamibi or Tc-99m tetrofosmin). Facility: [FACILITY_NAME]. SOP number: [SOP_NUMBER_PLACEHOLDER]. Review date: [REVIEW_DATE_PLACEHOLDER].
Include: (1) Protocol type — [PROTOCOL_TYPE_PLACEHOLDER]: 2-day rest/stress, 1-day low-dose rest/high-dose stress, pharmacologic stress protocol for patients unable to exercise; (2) Radiopharmaceutical — Tc-99m sestamibi [STRESS_DOSE_MCI_PLACEHOLDER] mCi stress dose / [REST_DOSE_MCI_PLACEHOLDER] mCi rest dose (or Tc-99m tetrofosmin — same doses); (3) Patient preparation requirements — NPO [FAST_HOURS_PLACEHOLDER] hours; hold caffeine 24 hours if adenosine/regadenoson stress; hold beta-blockers and calcium channel blockers [HOLD_HOURS_PLACEHOLDER] hours per physician order; IV access; EKG monitoring; crash cart available for stress lab; (4) Stress protocol — treadmill (Bruce or modified Bruce protocol) or pharmacologic agent ([PHARM_AGENT_PLACEHOLDER] — adenosine, regadenoson, dipyridamole; dosing and contraindications per SNMMI stress protocol guidelines); stress dose injected at peak stress (defined as [PEAK_STRESS_CRITERIA_PLACEHOLDER]); (5) Post-injection delay — [POST_STRESS_DELAY_PLACEHOLDER] minutes for sestamibi; [REST_DELAY_PLACEHOLDER] minutes for rest injection; (6) SPECT acquisition — camera: [CAMERA_PLACEHOLDER]; collimator: LEHR; matrix: [MATRIX_PLACEHOLDER]; projections: [PROJECTION_COUNT_PLACEHOLDER]; arc: [ARC_DEGREES_PLACEHOLDER] degrees; step-and-shoot or continuous rotation; gating: EKG-gated acquisition (8 or 16 frames per cardiac cycle); (7) Attenuation correction — [AC_PROTOCOL_PLACEHOLDER] (CT-based or transmission source); prone imaging for inferior wall artifact assessment; (8) Processing — iterative reconstruction protocol, attenuation correction, scatter correction; gated LVEF and wall motion; (9) Technologist QC before release — review for patient motion, EKG gating quality, attenuation artifact vs. perfusion defect. Write approximately 375–425 words in SOP format.24Protocol Deviation Report — Dose Administration Error (Dose Outside Protocol Range)
Write a protocol deviation report for a radiopharmaceutical dose administered outside the ordered or protocol-specified dose range. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME]. Date: [DEVIATION_DATE].
Deviation type: Radiopharmaceutical dose administered outside protocol-specified acceptable range. Radiopharmaceutical: [RP_NAME_PLACEHOLDER]. Ordered dose: [ORDERED_DOSE_MCI] mCi. Dose range acceptable per departmental protocol: [PROTOCOL_MIN_DOSE_PLACEHOLDER]–[PROTOCOL_MAX_DOSE_PLACEHOLDER] mCi. Dose administered: [ADMINISTERED_DOSE_MCI] mCi at [ADMIN_TIME]. Percentage deviation from ordered dose: [DEVIATION_PERCENT_PLACEHOLDER]%.
Discovery: Deviation identified at [DISCOVERY_POINT_PLACEHOLDER] (e.g., post-administration review of dose calibrator log; real-time check during administration; retrospective QC audit). Patient: [PATIENT_CONTEXT_PLACEHOLDER — no name or MRN] (e.g., adult male/female, [WEIGHT_PLACEHOLDER] kg, study indication: [INDICATION_PLACEHOLDER]).
NRC reportability assessment: Dose deviation [MEETS/DOES_NOT_MEET_PLACEHOLDER] NRC 10 CFR 35.3045 misadministration reporting threshold (effective dose equivalent >5 rem, organ dose >50 rem, or wrong patient/radiopharmaceutical/route). [REPORTABLE/NOT_REPORTABLE_PLACEHOLDER] — [RATIONALE_PLACEHOLDER].
Immediate action: Supervising physician Dr. [PHYSICIAN_NAME] notified at [NOTIFICATION_TIME]. Radiation Safety Officer [RSO_PLACEHOLDER] notified at [RSO_NOTIFICATION_TIME]. Patient dosimetry estimate: [DOSIMETRY_PLACEHOLDER] (calculated per [DOSIMETRY_METHOD_PLACEHOLDER]). Study impact assessment: [STUDY_IMPACT_PLACEHOLDER] (e.g., study interpretable — image quality adequate; study may require repeat at [REPEAT_TIMING_PLACEHOLDER] per physician discretion).
Root cause: [ROOT_CAUSE_PLACEHOLDER] (e.g., decay correction calculation error; dose calibrator assay at incorrect time; preparation error in dose drawing; incorrect protocol dose reference used). Corrective action: [CORRECTIVE_ACTION_PLACEHOLDER]. Write approximately 200–225 words in formal protocol deviation report format.25Radiopharmaceutical Inventory and Receipt Documentation
Write a radiopharmaceutical receipt and inventory log entry for a nuclear medicine department receiving a weekly radiopharmaceutical delivery. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Facility: [FACILITY_NAME]. Receipt Date: [RECEIPT_DATE]. Radiopharmacy: [RADIOPHARMACY_PLACEHOLDER].
Shipment receipt:
Package identification: [PACKAGE_ID_PLACEHOLDER]. Delivery carrier: [CARRIER_PLACEHOLDER]. Time of receipt: [RECEIPT_TIME]. Transport index (radiation level at package surface): [TRANSPORT_INDEX_PLACEHOLDER] mR/hr. NRC transport regulations compliance check: [TRANSPORT_COMPLIANCE_PLACEHOLDER] (labels present, package integrity intact, no damage noted).
Radiopharmaceuticals received (list each):
(1) [RP_1_NAME_PLACEHOLDER] — lot [LOT_1_PLACEHOLDER]; calibration date/time [CAL_1_DATE_TIME]; calibrated activity [CAL_1_ACTIVITY_MCI] mCi; expiration [EXP_1_PLACEHOLDER]; quantity: [QTY_1_PLACEHOLDER] vials/doses; QC certificate accompanying shipment: [QC_CERT_1_PLACEHOLDER] (yes — radionuclidic purity, radiochemical purity, pH, sterility, pyrogenicity test results included or available from radiopharmacy).
(2) [RP_2_NAME_PLACEHOLDER] — same fields as above.
(3) [RP_3_NAME_PLACEHOLDER] — same fields as above.
Dose calibrator assay on receipt: Performed by [TECH_NAME], CNMT at [ASSAY_TIME]. Measured vs. stated activities within [TOLERANCE_PLACEHOLDER]%: [ASSAY_RESULTS_PLACEHOLDER]. Any vials outside acceptable range: [DISCREPANCY_PLACEHOLDER].
Inventory update: Received items logged in departmental radioactive materials inventory per NRC license requirements. Storage location: [STORAGE_LOCATION_PLACEHOLDER] (hot lab — decay-in-storage area / refrigerator at [TEMP_PLACEHOLDER]°C). Receiving technologist: [TECH_NAME], CNMT. Radiation Safety Officer review: [RSO_PLACEHOLDER]. Write approximately 175–200 words in NRC-compliant radiopharmaceutical receipt and inventory log format.26New Procedure SOP — Lymphoscintigraphy / Sentinel Node Mapping
Write a new procedure SOP for lymphoscintigraphy and sentinel lymph node (SLN) mapping using Tc-99m sulfur colloid. This is a new procedure SOP being added to the department SOP manual. Facility: [FACILITY_NAME]. SOP number: [SOP_NUMBER_PLACEHOLDER]. Effective date: [EFFECTIVE_DATE_PLACEHOLDER]. Author: [TECH_NAME], CNMT. Medical director: Dr. [PHYSICIAN_NAME].
Include: (1) Purpose and clinical indication — intraoperative SLN identification for [INDICATIONS_PLACEHOLDER] (e.g., breast cancer staging, melanoma, endometrial cancer); procedure assists surgeon in identifying first-draining lymph node(s) from the primary tumor site to guide targeted biopsy; (2) Radiopharmaceutical — Tc-99m sulfur colloid (filtered, 0.1–0.22 micron filter to reduce particle size for lymphatic uptake), [DOSE_RANGE_MCI_PLACEHOLDER] mCi total divided into [INJECTION_COUNT_PLACEHOLDER] intradermal or peritumoral injections; preparation: [PREP_INSTRUCTIONS_PLACEHOLDER]; (3) Administration — performed by [INJECTING_PROVIDER_PLACEHOLDER] (physician or advanced practice provider per institutional scope of practice); technologist role: dose preparation, dose calibrator assay, documentation; (4) Imaging — dynamic imaging immediately post-injection ([DYNAMIC_PROTOCOL_PLACEHOLDER]); static images at [STATIC_TIMING_PLACEHOLDER] hours; SPECT/CT if needed for anatomic localization; (5) Skin marking — sentinel node location marked on patient skin surface with [MARKING_METHOD_PLACEHOLDER] under image guidance; surgeon notified; (6) Documentation requirements — dose administration record, imaging report, sentinel node location communicated to surgical team; (7) Intraoperative coordination — gamma probe availability and sterilization procedure for intraoperative use [PROBE_PROTOCOL_PLACEHOLDER]; (8) Radiation safety — PPE for handling Tc-99m; ALARA precautions for personnel and patient. Write approximately 375–425 words in numbered SOP format.27Patient Positioning and Acquisition Parameter Documentation — PET/CT
Write acquisition parameter documentation for an FDG PET/CT whole body oncology study. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Supervising Physician: Dr. [PHYSICIAN_NAME]. Facility: [FACILITY_NAME] PET/CT suite. Scanner: [PET_CT_SCANNER_PLACEHOLDER].
Patient positioning: Supine, arms [ARM_POSITION_PLACEHOLDER] (arms up above head preferred for body tumors to minimize attenuation artifact; arms down for head/neck or specific anatomic considerations per physician order). Head holder: [HEAD_HOLDER_PLACEHOLDER]. Immobilization devices: [IMMOBILIZATION_PLACEHOLDER] (e.g., none; knee cushion for comfort and reproducibility; thermoplastic mask for head/neck studies).
CT acquisition parameters (low-dose attenuation correction CT): kVp [KVP_PLACEHOLDER], mA [MA_PLACEHOLDER] (automated exposure control — [AEC_SETTING_PLACEHOLDER]), rotation time [ROTATION_PLACEHOLDER] s, pitch [PITCH_PLACEHOLDER], slice thickness [SLICE_THICKNESS_PLACEHOLDER] mm, DFOV [DFOV_PLACEHOLDER] mm. Contrast: [CONTRAST_STATUS_PLACEHOLDER] (no contrast — AC only; IV contrast administered — see contrast administration note).
PET acquisition parameters: Scan range: [SCAN_RANGE_PLACEHOLDER] (vertex to mid-thigh; vertex to toes for melanoma per physician order). Number of bed positions: [BED_POSITIONS_PLACEHOLDER]. Time per bed position: [TIME_PER_BED_PLACEHOLDER] minutes (2D or 3D mode). Reconstruction protocol: [RECONSTRUCTION_PLACEHOLDER] (e.g., OSEM iterative reconstruction, [SUBSETS_PLACEHOLDER] subsets, [ITERATIONS_PLACEHOLDER] iterations, [GAUSSIAN_FILTER_PLACEHOLDER] mm Gaussian post-filter, TOF if available). Attenuation correction: CT-based. Scatter correction: [SCATTER_CORRECTION_PLACEHOLDER].
Quality review: Motion artifact assessment [MOTION_ASSESSMENT_PLACEHOLDER]; CT-PET misregistration check [MISREGISTRATION_CHECK_PLACEHOLDER]; image quality assessment before patient discharge — [QUALITY_STATUS_PLACEHOLDER]. Physician notified for any quality issues: [PHYSICIAN_NOTIFICATION_PLACEHOLDER]. Write approximately 175–200 words in PET/CT acquisition parameter documentation format.28Radioactive Material Storage and Disposal Log Entry
Write a radioactive material storage area daily check and waste disposal log entry for a nuclear medicine department. Use de-identified placeholders only. Technologist: [TECH_NAME], CNMT. Radiation Safety Officer: [RSO_PLACEHOLDER]. Facility: [FACILITY_NAME]. Date: [LOG_DATE].
Daily storage area check:
Time of check: [CHECK_TIME]. Technologist: [TECH_NAME], CNMT.
Radioactive material storage area: [STORAGE_AREA_PLACEHOLDER] (e.g., hot lab lead-lined refrigerator, decay-in-storage room, radioactive waste storage area).
Radiation level at storage area door/exterior: [RADIATION_LEVEL_PLACEHOLDER] mR/hr (acceptable per posted limit of [POSTED_LIMIT_PLACEHOLDER] mR/hr).
Posted signage current (Caution — Radioactive Material): [SIGNAGE_STATUS_PLACEHOLDER] (yes / no — replaced at [TIME_PLACEHOLDER]).
Lock/access security: [SECURITY_STATUS_PLACEHOLDER] (secure — combination/key lock intact; authorized personnel only access confirmed).
Temperature (if refrigerated pharmaceuticals stored): [TEMP_PLACEHOLDER]°C (acceptable range [TEMP_RANGE_PLACEHOLDER]).
Inventory present: [INVENTORY_SUMMARY_PLACEHOLDER] (e.g., Tc-99m MDP — [VIALS_PLACEHOLDER] vials; I-131 capsules — [COUNT_PLACEHOLDER] capsules in locked safe; radioactive waste containers — [CONTAINER_COUNT_PLACEHOLDER]).
Decay-in-storage waste disposal log:
Isotope: [WASTE_ISOTOPE_PLACEHOLDER]. Container ID: [CONTAINER_ID_PLACEHOLDER]. Date placed in storage: [STORAGE_DATE_PLACEHOLDER]. Half-lives elapsed since storage: [HALF_LIVES_PLACEHOLDER]. Background reading on container: [BACKGROUND_PLUS_CONTAINER_PLACEHOLDER] mR/hr. Survey meter used: [SURVEY_METER_PLACEHOLDER] (calibration current through [CAL_DATE_PLACEHOLDER]). Release for disposal as non-radioactive waste: [RELEASE_STATUS_PLACEHOLDER] — at or below twice background. Disposal method: [DISPOSAL_METHOD_PLACEHOLDER]. Radioactive labels removed: [LABEL_STATUS_PLACEHOLDER]. RSO notification of disposal: [RSO_NOTIFICATION_PLACEHOLDER]. Write approximately 175–200 words in radioactive material storage and decay-in-storage disposal log format consistent with NRC 10 CFR 35 requirements.Section 5Career Development & CNMT Exam Prep
The CNMT (Certified Nuclear Medicine Technologist) credential through the Nuclear Medicine Technology Certification Board (NMTCB), along with the N (Nuclear Medicine Technology) specialty certification through ARRT, represents the professional standard in nuclear medicine technology. But the exam prep, resume, cover letter, and LinkedIn profile never seem to make it onto the priority list after a 12-scan day managing radiopharmaceuticals, QC, and patient education simultaneously. These 7 prompts generate every career document a nuclear medicine technologist needs — from CNMT/ARRT-N exam study guides to job application materials to professional development plans.
29CNMT/ARRT-N Exam Study Guide — Radiopharmaceuticals and Dosimetry
Create a structured self-study guide for the CNMT (NMTCB) or ARRT-N nuclear medicine technology certification examination covering radiopharmaceutical properties and radiation dosimetry. Include:
(1) Radiopharmaceutical properties by category:
- Tc-99m agents: MDP (bone), sestamibi (myocardial perfusion, parathyroid), MAA (lung perfusion), DTPA (renal, lung ventilation), sulfur colloid (liver/spleen, lymphoscintigraphy), HMPAO (brain perfusion), MAG3 (renal), tetrofosmin (myocardial perfusion) — for each: target organ, mechanism of uptake, imaging time, typical adult dose range in mCi
- Iodine agents: I-123 (diagnostic thyroid uptake and scan), I-131 (thyroid ablation therapy) — physical half-life, energy, imaging vs. therapeutic use distinction, key preparation requirements
- PET radiopharmaceuticals: F-18 FDG (oncology, cardiac, brain), Rb-82 (myocardial perfusion PET) — physical half-life, mechanism, clinical applications, blood glucose requirement for FDG
(2) Radiation dosimetry fundamentals:
- Units: Gray (Gy) vs. rad; Sievert (Sv) vs. rem; Becquerel (Bq) vs. Curie (Ci) — conversions
- Effective dose vs. absorbed dose vs. equivalent dose — definitions and clinical relevance
- ALARA principle — as low as reasonably achievable; practical applications in NMT workflow
- Physical half-life vs. effective half-life vs. biological half-life — formula and clinical example
(3) Radiation safety limits (NRC 10 CFR 20):
- Occupational dose limits: whole body, extremities, eye lens
- Public dose limits
- Embryo/fetus dose limits for declared pregnant worker
- NRC release criteria for patients (10 CFR 35.75) — 33 mCi / 7 mrem/hr threshold
(4) Sample exam questions with worked answers — 5 questions covering radiopharmaceutical dosimetry, half-life calculations, and ALARA application.
Format: table for radiopharmaceutical properties; numbered list for dosimetry; worked calculation example. Approximately 400–450 words.30Resume Bullet Points for Nuclear Medicine Technologist
Write strong, results-oriented resume bullet points for a nuclear medicine technologist or CNMT position. Role: [ROLE_TITLE] (e.g., Nuclear Medicine Technologist, Senior NMT, Lead CNMT, Nuclear Medicine Technology Supervisor). Facility type: [FACILITY_TYPE] (e.g., high-volume academic medical center nuclear medicine department, community hospital, dedicated cardiac imaging center, PET/CT outpatient imaging center, VA medical center). Key responsibilities: [RESPONSIBILITIES] (e.g., daily gamma camera QC, radiopharmaceutical preparation and administration, bone scans, cardiac stress SPECT, PET/CT, thyroid uptakes and scans, sentinel node mapping, patient education, NRC compliance documentation, radiopharmaceutical inventory management, SNMMI accreditation compliance). Volume metrics (de-identified): [VOLUME_PLACEHOLDER] (e.g., performed [X] nuclear medicine studies per shift across [MODALITIES_PLACEHOLDER] modalities; administered [X] radiopharmaceuticals per week). Format: strong action-verb bullets, 12–15 words each, quantified where possible. Generate 8–10 bullets. Avoid "responsible for." Open with action verbs: Administered, Performed, Documented, Maintained, Managed, Achieved, Trained, Reduced, Ensured, Coordinated. Use NMT-specific terminology: Tc-99m, CNMT, SNMMI, dose calibrator, gamma camera, CFOV/DFOV uniformity, SPECT/CT, PET/CT, NRC compliance, radiopharmaceutical inventory, ALARA.31Cover Letter for Senior Nuclear Medicine Technologist / Lead NMT
Write a professional cover letter for a senior nuclear medicine technologist or lead NMT position. Applicant credential: [YOUR_CREDENTIAL] (e.g., CNMT with [X] years experience, CNMT(CT), ARRT(N)(CT), CNMT and PET specialty). Target role: [ROLE_TITLE] at [FACILITY_NAME_PLACEHOLDER]. Key experience: [EXPERIENCE_HIGHLIGHTS] (e.g., high-volume nuclear medicine operations, gamma camera QC program management, radiopharmaceutical preparation and NRC compliance, cardiac nuclear stress lab experience, PET/CT operations, SNMMI accreditation preparation, new staff training and orientation, QC failure management, patient radiation safety education, thyroid ablation therapy support). Certifications: [CERTIFICATIONS_PLACEHOLDER] (e.g., CNMT via NMTCB, ARRT-N, CNMT(CT), PET specialty, ACLS if applicable). Why this facility: [REASON_PLACEHOLDER]. Tone: confident, clinically specific, professional. Approximately 275–300 words. Do not open with "I am writing to express my interest." Start with a strong sentence that leads with clinical value — something specific about what you bring to nuclear medicine department quality, throughput, and NRC compliance. Standard cover letter format.32Nuclear Medicine Job Interview Questions and Answers
Generate 7 common nuclear medicine technologist job interview questions with detailed answer frameworks. Include:
(1) Walk me through your daily workflow in a busy nuclear medicine department — from opening QC to last patient.
(2) Describe a time a gamma camera uniformity QC failed before a full schedule. What did you do?
(3) How do you ensure radiopharmaceutical dose accuracy from receipt through administration on a high-volume day?
(4) What is your experience with cardiac nuclear stress testing, and what do you do when a patient has a contraindication to exercise stress?
(5) Describe a patient who was anxious about receiving a radioactive material. How did you explain the procedure and address their concerns?
(6) How do you approach training a new nuclear medicine technologist who is coming from a program but has no department-specific experience?
(7) Why do you want to work at [FACILITY_TYPE_PLACEHOLDER], and what do you see as the most important quality you bring to a nuclear medicine team?
For each question: provide a 100–130 word answer framework using the STAR method (Situation, Task, Action, Result) with specific nuclear medicine terminology — radiopharmaceutical names, QC parameters (CFOV/DFOV), NRC regulatory requirements, SNMMI guidelines, ALARA, patient education language. Approximately 800–900 words total.33CNMT Exam Study Plan — 6-Week Schedule
Write a 6-week self-study plan for the CNMT (Certified Nuclear Medicine Technologist) examination through the NMTCB (Nuclear Medicine Technology Certification Board). Exam target: CNMT via NMTCB. Exam date: [EXAM_DATE_PLACEHOLDER]. Current experience level: [EXPERIENCE_LEVEL] (e.g., completing nuclear medicine technology program clinical practicum, 12 months of NMT experience, cross-training from radiologic technology). Weak topic areas to prioritize: [WEAK_AREAS] (e.g., radiopharmaceutical chemistry and dosimetry, NRC regulations 10 CFR 35, gamma camera QC parameters, cardiac nuclear stress protocols, radiation protection calculations, renal nuclear medicine). Study resources available: [RESOURCES] (e.g., NMTCB practice exams, SNM Procedures and Instrumentation textbook, SNMMI practice guidelines, departmental SOPs and QC manuals, online question banks). Study hours per week: [STUDY_HOURS_PLACEHOLDER].
Week-by-week schedule:
Week 1 — Radiopharmaceuticals and basic nuclear physics: isotope properties, decay equations, half-life calculations, production methods, radiopharmaceutical preparation and quality control.
Week 2 — Instrumentation and gamma camera QC: detector physics, collimators, CFOV/DFOV uniformity, spatial resolution, energy resolution, dose calibrator QC, survey meter calibration.
Week 3 — NRC regulations and radiation safety: 10 CFR 35, occupational dose limits, patient release criteria (10 CFR 35.75), misadministration/recordable events, ALARA, survey requirements.
Week 4 — Clinical procedures and protocols: bone scan, cardiac SPECT, thyroid uptake and scan, renal studies, PET/CT, lymphoscintigraphy — indications, preparation, acquisition, dosing.
Week 5 — Patient care and pharmacology: patient preparation, contrast considerations, pharmacologic stress agents, adverse reactions, pediatric dosing, pregnant patient guidelines.
Week 6 — Full-length timed practice exams and weak-area review: two full-length NMTCB-format practice exams, review incorrect answers, focus on high-yield weak areas identified in weeks 1–5.
Include daily topic checkpoints and end-of-week self-quiz targets. Approximately 350–400 words.34LinkedIn Professional Bio for a Certified Nuclear Medicine Technologist
Write a professional LinkedIn summary or bio for a certified nuclear medicine technologist. Credential: [CREDENTIAL] (e.g., CNMT via NMTCB, ARRT-N, CNMT(CT), PET specialist). Years of experience: [YEARS_EXPERIENCE]. Facility types: [FACILITY_TYPES] (e.g., high-volume academic nuclear medicine department, community hospital, cardiac imaging center, PET/CT outpatient center). Key strengths: [KEY_STRENGTHS] (e.g., gamma camera QC program management, Tc-99m radiopharmaceutical preparation, cardiac stress SPECT, PET/CT operations, thyroid ablation therapy support, sentinel lymph node mapping, patient radiation safety education, NRC compliance documentation, SNMMI accreditation preparation, new technologist training). Career direction: [CAREER_GOAL] (e.g., advancing to lead CNMT or nuclear medicine department supervisor, pursuing PET specialty credential, cross-training in CT, transitioning to nuclear medicine physicist assistant program, healthcare quality and compliance). Tone: professional but personable — reads like a real person, not a job description. Approximately 175–200 words. First person. Do not start with "I am a nuclear medicine technologist." Lead with what you bring to patient safety, imaging quality, and department performance. Include specific clinical language — radiopharmaceuticals, camera QC, NRC, ALARA — that demonstrates technical depth to hiring managers in nuclear medicine.356-Month Professional Development Plan — Nuclear Medicine Technologist
Write a 6-month professional development plan for a nuclear medicine technologist. Current role and experience level: [CURRENT_ROLE_AND_YEARS]. Career goal at 6 months: [SIX_MONTH_GOAL] (e.g., earn CNMT credential via NMTCB, pass ARRT-N specialty examination, earn PET specialty certification, advance to lead NMT or nuclear medicine supervisor, cross-train in CT for CNMT(CT) credential, complete a continuing education cycle for CNMT renewal). Month-by-month milestones:
Month 1: Complete a baseline CNMT or ARRT-N practice assessment to identify the top 3 weak content areas; review the current NMTCB or ARRT-N content specifications document; enroll in exam prep program or question bank of choice; meet with supervisor to align development goals with department needs.
Month 2: Complete radiopharmaceutical chemistry and dosimetry self-study module; review NRC 10 CFR 35 regulations with focus on recordable events, release criteria, and dose calibrator requirements; complete at least 2 timed practice quizzes on this content area.
Month 3: Complete instrumentation and gamma camera QC module — CFOV/DFOV uniformity standards, spatial resolution, energy resolution, weekly and monthly QC requirements; shadow medical physicist during next scheduled gamma camera acceptance testing or annual QC if available.
Month 4: Complete clinical procedures module — bone scan, cardiac SPECT, thyroid uptake/scan, renal studies, PET/CT protocols — review your facility's SOPs alongside SNMMI practice guidelines; review patient radiation safety and NRC release requirements for therapeutic procedures.
Month 5: Complete pharmacologic stress protocols, patient care, and pediatric dosing module; take first full-length timed CNMT or ARRT-N practice exam under exam conditions; review all incorrect answers and return to content review for remaining weak areas.
Month 6: Sit for the CNMT or ARRT-N examination (if eligible) or submit application for next test date; complete all continuing education or documentation requirements for the chosen credential; if exam passed — update resume, LinkedIn, and SNMMI member profile; submit development plan summary to supervisor.
Resources needed: [RESOURCES_PLACEHOLDER]. How to measure success: [SUCCESS_METRICS_PLACEHOLDER]. Approximately 300–350 words with month-by-month milestone headers.SNMMI, EANM, NRC & HIPAA: What Nuclear Medicine Technologists Need to Know Before Using ChatGPT
Nuclear Medicine Physician Review Required — AI Does Not Replace Physician Sign-Off
All report addendums, protocol deviation reports, QC failure narratives, patient education materials, and corrective action plans generated using these prompts must be reviewed and approved by your supervising nuclear medicine physician before filing or distribution. AI-generated documentation is a drafting efficiency tool — not a substitute for the clinical expertise, regulatory knowledge, and professional judgment of your nuclear medicine physician and radiation safety officer. Never file a QC failure log, deviation report, or NRC-regulated document without supervisor sign-off. Never distribute radiation safety patient education without physician review and confirmation that the content matches your facility's NRC license conditions and approved release criteria.
HIPAA — De-identify All PHI Before Entering Any Prompt
Standard ChatGPT has no Business Associate Agreement (BAA) with healthcare facilities. Never enter real patient names, dates of birth, MRNs, dose calibrator serial numbers tied to specific patients, or any Protected Health Information (PHI) into ChatGPT. Use placeholder variables in every prompt: [TECH_NAME], [PHYSICIAN_NAME], [DOSE_MCI], [QC_DATE], [ACCESSION_PLACEHOLDER], [PATIENT_CONTEXT]. Generate documentation using placeholders, then populate actual case data only inside your facility's RIS, NM information system, or EHR after reviewing and approving the AI-generated draft. If your facility has deployed a HIPAA-covered AI documentation tool integrated into your nuclear medicine information system, use that platform for any patient-specific documentation.
SNMMI/EANM Practice Guidelines and NRC Regulations — Verify Against Current Standards
All SNMMI practice guideline references, EANM procedure guideline references, and NRC regulatory citations (10 CFR 35) in these prompts are based on published standards. These standards are updated regularly — SNMMI releases updated procedure guidelines periodically, and NRC regulations are subject to rulemaking. All AI-generated protocol documentation, QC standards references, and NRC compliance language must be verified against your facility's current applicable SNMMI/EANM guidelines, NRC 10 CFR 35 regulations, and your facility's specific NRC license conditions before use in formal documentation or inspection preparation. Always confirm current regulatory thresholds (release criteria, dose calibrator tolerances, uniformity QC thresholds) with your supervising physician and radiation safety officer.
ALARA Principle and Radiation Safety Documentation — Facility RSO Review Required
All radiation safety communications, NRC-regulated patient education materials (including RAI-131 discharge instructions per 10 CFR 35.75), radioactive spill reports, and misadministration or recordable event documentation require review by your facility's Radiation Safety Officer (RSO) and must comply with your facility's NRC license, radiation safety program, and applicable Agreement State regulations before distribution or filing. AI drafts radiation safety documentation templates; it does not determine NRC reportability, validate your facility's specific license conditions, or replace the judgment of your RSO. The ALARA principle requires that all radiation exposures — to patients, personnel, and the public — be kept as low as reasonably achievable. AI-generated communications must be reviewed to confirm they accurately reflect your facility's ALARA program and NRC license requirements.
NovaFlow — AI Tools That Print Money
Clear the Documentation Queue. Finish Your Shift.
The Ultimate AI Toolkit Bundle includes the AI Prompt Bible, 500 Social Media Captions, and every NovaFlow tool in one package. Built for nuclear medicine professionals who want AI working across their entire workflow — from gamma camera QC logs to RAI patient education to CNMT exam prep.
More from the NovaFlow blog:
- ChatGPT for EKG/Cardiac Monitor Technicians: 35 Prompts to Write Rhythm Strip Documentation, Telemetry Reports, and Clinical Communications Faster →
- ChatGPT for Phlebotomists: 35 Prompts to Write Incident Reports, Patient Education, and Career Documents Faster →
- ChatGPT for Pharmacy Technicians: 35 Prompts to Write Patient Communications, Drug Information Sheets, and Work Documents Faster →
- ChatGPT for Nurses: 35 Prompts to Write Patient Education, Care Plans, and Clinical Documentation Faster →
- ChatGPT for Medical Assistants: 35 Prompts to Write Patient Notes, Prior Authorizations, and Clinical Documents Faster →